Autophagy inhibition upregulates CD4+ tumor infiltrating lymphocyte expression via miR‐155 regulation and TRAIL activation
Open Access
- 16 September 2016
- journal article
- Published by Wiley in Molecular Oncology
- Vol. 10 (10) , 1516-1531
Abstract
Chemoresistance is a major challenge in lung cancer treatment. Recent findings have revealed that autophagic mechanism contributes significantly to immunosuppressive related chemoresistance. For that reason, targeting autophagy‐related immunosuppression is an important approach to reverse tumor drug resistance. In this study, we report for the first time that autophagy inhibition triggers upregulation of CD4+, Foxp3+ tumor infiltrating lymphocytes in late metastatic lung cancer tissues. Furthermore, autophagy blockage induces chemosensitization to carboplatin, immune activation and cell cycle arrest. This induction correlated with reduction in expression of drug resistance genes MDR1, MRP1, ABCG2 and ABCC2 along with decreased expression of PD‐L1 which is associated with severe dysfunction of tumor specific CD8+ T cells. Furthermore, experiments revealed that co‐treatment of carboplatin and autophagy inhibitor chloroquine increased lung tissue infiltration by CD4+, FoxP3+ lymphocytes and antigen‐specific immune activation. Subsequent ex vivo experiments showed the activation of carboplatin related TRAIL‐dependent apoptosis through caspase 8 and a synergistic role of miR‐155 in lung tissue infiltration by CD4+, and FoxP3+ lymphocytes. Overall, our results indicate that autophagy blockage increases lung cancer chemosensitivity to carboplatin, but also reveal that miR‐155 functions as a novel immune system activator by promoting TILs infiltration. These results indicate that targeting of autophagy can prevent cancer related immunosuppression and elucidate immune cell infiltration in tumor microenvironment thus representing a potential therapeutic strategy to inhibit lung cancer progression and metastasis.Keywords
Funding Information
- ΙΚΥ Fellowship – Siemens Program
This publication has 52 references indexed in Scilit:
- MiR-205 and miR-218 expression is associated with carboplatin chemoresistance and regulation of apoptosis via Mcl-1 and Survivin in lung cancer cellsCellular Signalling, 2015
- The Clinical Relevance of the miR-197/CKS1B/STAT3-mediated PD-L1 Network in Chemoresistant Non-small-cell Lung CancerMolecular Therapy, 2015
- Tumor suppressor miR-34a targets PD-L1 and functions as a potential immunotherapeutic target in acute myeloid leukemiaCellular Signalling, 2015
- Targeting Hedgehog signaling pathway and autophagy overcomes drug resistance of BCR-ABL-positive chronic myeloid leukemiaAutophagy, 2015
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppressionNature Communications, 2014
- Induction of a specific CD8+ T-cell response to cancer/testis antigens by demethylating pre-treatment against osteosarcomaOncotarget, 2014
- Clinically relevant determinants of body composition, function and nutritional status as mortality predictors in lung cancer patientsLung Cancer, 2014
- Risk factors and survival outcome for non-elective referral in non-small cell lung cancer patients – Analysis based on the National Lung Cancer AuditLung Cancer, 2014
- Autophagy regulation and its role in cancerSeminars in Cancer Biology, 2013
- The Prognostic Value of FoxP3+ Tumor-Infiltrating Lymphocytes in Cancer: A Critical Review of the LiteratureClinical Cancer Research, 2012